Value-based cancer care platform Thyme Care announced it secured $60 million in Series B funding co-led by Foresite Capital and Town Hall Ventures, bringing its total raise to over $80 million.
Current investors Andreessen Horowitz BIO + Health, Casdin Capital, Frist Cressey Ventures and AlleyCorp participated in the round.
Town Hall Ventures' cofounder and general partner David Whelan will...
Medical AI startup Qritive has pooled $7.5 million in a funding round led by MassMutual Ventures and supported by Enterprise Singapore's investment arm SEEDS Capital and Exfinity Venture Partners.
WHAT IT DOES
Founded in 2017, the Singapore-headquartered company offers diagnostic support solutions that provide fast and accurate pathological interpretations "within seconds." Its digital pathology...
Disclaimer: Flare Capital Partners is an investor in Aetion, Cohere Health, HealthVerity, Inbound Health, Iora Health and VivorCare. See the broader Flare presentation here.
In part one of this article, we highlighted the various components of end-to-end cancer care delivery and management and how innovators have emerged to address today’s unmet needs. We unbundled the key challenges opposing...
Disclaimer: Flare Capital Partners is an investor in Aetion, Cohere Health, HealthVerity, Inbound Health, Iora Health and VivorCare. See the broader Flare presentation here.
This is part one of a two-part series on innovation in cancer care delivery. In part one, we will discuss the complexity of end-to-end cancer care management, the unmet needs and how some emerging digital health players...
Researchers from the Indian Institute of Technology in Madras have come up with a new AI prediction tool that can detect cancer-causing genes in individuals.
WHAT IT DOES
Dubbed PIVOT, the AI tool is based on a prediction model that uses information on mutations, expression of genes, and copy number variation in genes and perturbations in the biological network due to an altered gene expression....
Karkinos Healthcare, a technology-driven cancer care platform in India, has entered into a strategic partnership with American oncology diagnostics firm C2i Genomics to promote AI-enabled cancer monitoring in the country.
According to a press statement, their partnership will expand minimal residual disease (MRD) monitoring across Karkinos' network using C2i Genomics' whole-genome analysis...
Weekly electronic symptom-tracking surveys improved physical function, symptom control and health-related quality of life among cancer patients, according to a study published in JAMA.
In a randomized trial that included 52 practices and 1,191 patients receiving treatment for metastatic cancer, researchers found statistically significant improvements in secondary outcomes like function and...
Direct primary care startup Hint Health raised $45 million in a funding round led by Banneker Partners and Frist Cressey Ventures, bringing its total raise to $60 million.
Hint offers a platform where providers can enroll patients as members and directly bill for services. The company said the funding will go toward growing its operating system and expanding its primary care provider network....
Drug discovery startup ArrePath announced Thursday it has raised $20 million in a seed funding round led by the Boehringer Ingelheim Venture Fund, Insight Partners and Innospark Ventures.
Other participants in the round include Viva BioInnovator, Arimed Capital, PTX Capital and Nor’easter Ventures. The company, which focuses on developing new types of anti-infective drugs to best antimicrobial...
Indian digital health startup MFine has launched a cancer screening feature on its app in partnership with oncology research and solutions provider Datar Cancer Genetics.
MFine users can now book a range of cancer diagnostic tests from Datar's EasyCheck.
EasyCheck is a non-invasive, radiation-free test for early cancer detection. It has three types of test: EasyCheck360 detects cancer from...